Summary
Boston Scientific Corporation (BSX) filed an 8-K on January 13, 2006, to announce the submission of a revised definitive offer to acquire Guidant Corporation. This filing provides details regarding the revised offer letter and a proposed merger agreement submitted by Boston Scientific to Guidant's Chairman. This strategic move signals Boston Scientific's continued pursuit of Guidant, despite other potential acquirers, and indicates a significant potential expansion for BSX. Investors should note that this filing is part of an ongoing negotiation process. The company emphasizes that the submitted documents are not substitutes for a formal prospectus/proxy statement, which will be filed if a definitive agreement is reached. Shareholders are strongly advised to review these future filings for comprehensive information regarding the proposed transaction and its potential impact. The report also clarifies that Boston Scientific is not currently soliciting proxies.
Key Highlights
- 1Boston Scientific submitted a revised definitive offer to acquire Guidant Corporation on January 12, 2006.
- 2The offer was formally communicated via a letter from BSX Chairman and CEO to Guidant's Chairman.
- 3A signed copy of the proposed merger agreement between Boston Scientific and Guidant was also delivered.
- 4This filing serves as an update on the ongoing acquisition efforts for Guidant.
- 5BSX is providing key transaction documents (offer letter and merger agreement) as exhibits.
- 6Investors are urged to read future prospectus/proxy statements for detailed information, once available.
- 7The filing clarifies that BSX is not currently soliciting proxies in connection with the proposed transaction.